Compounds > adenosine diphosphate
Page last updated: 2024-08-17

adenosine diphosphate and quinoxalines

adenosine diphosphate has been researched along with quinoxalines in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's3 (30.00)18.2507
2000's5 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paris, H; Remaury, A1
Flavahan, NA; Shimokawa, H; Vanhoutte, PM1
Hollier, LH; Miller, VM; Reigel, MM; Vanhoutte, PM1
Cambria, RA; Gloviczki, P; Lowell, RC; Miller, VM1
Flavahan, NA1
Magid, KS; Megson, IL; Shaw, CA; Sogo, N; Webb, DJ1
Duszyk, M; Jurasz, P; Mayers, I; Miranda, C; Radomski, MW; Sawicka, J; Sawicki, G1
Anfossi, G; Cavalot, F; Massucco, P; Mattiello, L; Russo, I; Trovati, M1
Homer, KL; Wanstall, JC1
Badimon, L; Salas, E; Segalés, E; Vilahur, G1

Other Studies

10 other study(ies) available for adenosine diphosphate and quinoxalines

ArticleYear
The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:1

    Topics: Adenosine Diphosphate; Adrenergic alpha-Antagonists; Animals; Binding Sites; Brimonidine Tartrate; Cell Line; Cyclic AMP; Dioxanes; GTP-Binding Proteins; Idazoxan; Immunoblotting; Insulin; Insulin Secretion; Kinetics; Membranes; Pertussis Toxin; Quinoxalines; Rats; Receptors, Adrenergic, alpha; Tritium; Virulence Factors, Bordetella; Yohimbine

1992
Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein.
    Circulation research, 1989, Volume: 65, Issue:3

    Topics: Adenosine Diphosphate; Animals; Antihypertensive Agents; Blood Platelets; Bradykinin; Brimonidine Tartrate; Calcimycin; Coronary Vessels; Dinoprost; Endothelium, Vascular; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Pertussis Toxin; Potassium Chloride; Quinoxalines; Serotonin; Swine; Thrombin; Virulence Factors, Bordetella

1989
Endothelium-dependent responses in autogenous femoral veins grafted into the arterial circulation of the dog.
    The Journal of clinical investigation, 1987, Volume: 80, Issue:5

    Topics: Acetylcholine; Adenosine Diphosphate; Adrenergic alpha-Agonists; Animals; Arachidonic Acid; Arachidonic Acids; Arteries; Brimonidine Tartrate; Calcimycin; Dogs; Endothelium; Femoral Vein; Indomethacin; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Quinoxalines; Thrombin

1987
Chronic changes in blood flow alter endothelium-dependent responses in autogenous vein grafts in dogs.
    Journal of vascular surgery, 1994, Volume: 20, Issue:5

    Topics: Acetylcholine; Adenosine Diphosphate; Adrenergic alpha-Agonists; Animals; Arginine; Arteriovenous Shunt, Surgical; Blood Flow Velocity; Brimonidine Tartrate; Calcimycin; Constriction; Dinoprost; Dogs; Endothelins; Endothelium, Vascular; Femoral Artery; Femoral Vein; Hyperplasia; Male; Models, Biological; Neovascularization, Pathologic; Nitric Oxide; omega-N-Methylarginine; Quinoxalines; Thrombin; Tunica Intima; Vascular Patency

1994
Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells.
    The American journal of physiology, 1993, Volume: 264, Issue:3 Pt 2

    Topics: Adenosine Diphosphate; Animals; Bradykinin; Brimonidine Tartrate; Coronary Vessels; Dinoprost; Endothelium, Vascular; Female; Fluorides; GTP-Binding Proteins; Lysophosphatidylcholines; Male; Muscle Contraction; Pertussis Toxin; Quinoxalines; Serotonin; Signal Transduction; Swine; Virulence Factors, Bordetella

1993
Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Biochemical and biophysical research communications, 2000, Dec-20, Volume: 279, Issue:2

    Topics: Adenosine Diphosphate; Adult; Blood Platelets; Collagen; Cyclic GMP; Enzyme Inhibitors; Glucosamine; Glutathione; Humans; In Vitro Techniques; Kinetics; Models, Biological; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Nitroso Compounds; Oxadiazoles; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; Quaternary Ammonium Compounds; Quinoxalines; S-Nitrosoglutathione

2000
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Cancer research, 2001, Jan-01, Volume: 61, Issue:1

    Topics: Adenosine Diphosphate; Blood Platelets; Cell Communication; Enzyme Inhibitors; Epoprostenol; Fibrosarcoma; Gelatinases; Glutathione; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Neoplasms, Experimental; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Penicillamine; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinoxalines; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Thromboxane A2; Tumor Cells, Cultured

2001
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets.
    European journal of clinical investigation, 2001, Volume: 31, Issue:5

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Acetylcysteine; Adenosine Diphosphate; Adult; Calcimycin; Cell Membrane Permeability; Collagen; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Humans; Ionomycin; Male; omega-N-Methylarginine; Oxadiazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinones; Quinoxalines

2001
Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
    British journal of pharmacology, 2002, Volume: 137, Issue:7

    Topics: Adenosine Diphosphate; Animals; Catalase; Collagen; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activators; Enzyme Inhibitors; Guanylate Cyclase; Hydrazines; In Vitro Techniques; Indazoles; Male; Nitric Oxide Donors; Oxadiazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Artery; Quinoxalines; Rats; Rats, Wistar; S-Nitrosoglutathione; Superoxide Dismutase; Thapsigargin; Thionucleotides; Vasoconstriction

2002
Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Circulation, 2004, Sep-21, Volume: 110, Issue:12

    Topics: Adenosine Diphosphate; Amino Acids; Animals; Aspirin; Benzoates; Blood Pressure; Clopidogrel; Collagen; Cyclooxygenase Inhibitors; Drug Evaluation; Drug Therapy, Combination; Fibrinolytic Agents; Free Radical Scavengers; Guanylate Cyclase; Heart Rate; Hemorheology; Imidazoles; Membrane Proteins; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Quinoxalines; Random Allocation; Receptors, Purinergic P2Y12; rhoA GTP-Binding Protein; Sus scrofa; Thrombosis; Ticlopidine

2004